Haas, D W <br/><br/>
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine.  [electronic resource] 

 -  AIDS (London, England)  Sep 2000 
 - 1973-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/00002030-200009080-00013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--adverse effects<br/>Antiretroviral Therapy, Highly Active<br/>CD4 Lymphocyte Count<br/>Drug Administration Schedule<br/>HIV Infections--drug therapy<br/>HIV-1--isolation & purification<br/>Humans<br/>Indinavir--administration & dosage<br/>Lamivudine--adverse effects<br/>Pilot Projects<br/>RNA, Viral--blood<br/>Reverse Transcriptase Inhibitors--adverse effects<br/>Treatment Outcome<br/>Viral Load<br/>Zidovudine--adverse effects